Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Lanting Fuh"'
Autor:
Michelle Maguire, Bryan D. Hayes, Lanting Fuh, Ramy Elshaboury, Ronak G. Gandhi, Sarah Bor, Erica S. Shenoy, Anna R. Wolfson, Christian M. Mancini, Kimberly G. Blumenthal
Publikováno v:
World Allergy Organization Journal, Vol 13, Iss 1, Pp - (2020)
Background: Facilitating beta-lactam antibiotic use in patients reporting beta-lactam allergies in acute care settings is important to individual patient outcomes and public health; however, few initiatives have targeted the Emergency Department (ED)
Externí odkaz:
https://doaj.org/article/314f895005d649188f100a1628698eee
Autor:
Michelle Maguire, Lanting Fuh, Joshua N. Goldstein, Ariela L. Marshall, Michael Levine, Melissa L. Howell, Blair A. Parry, Rachel Rosovsky, Bryan D. Hayes
Publikováno v:
Western Journal of Emergency Medicine, Vol 20, Iss 4 (2019)
Introduction: Warfarin is a potent anticoagulant used for the prevention and treatment of venous and arterial thrombosis. Occasionally, patients require emergent warfarin reversal due to active bleeding, supratherapeutic international normalized rati
Externí odkaz:
https://doaj.org/article/c4e6b03f562843428a3880c336de40db
Publikováno v:
Western Journal of Emergency Medicine, Vol 19, Iss 5 (2018)
Introduction: Advancements in the treatment of warfarin-associated intracranial hemorrhage (ICH) include the use of four-factor prothrombin complex concentrate (4F-PCC), which has demonstrated more rapid reversal of the international normalized ratio
Externí odkaz:
https://doaj.org/article/53009528e5ea47498083bd987eccbe3c
Autor:
Jessica M, Mason, James R, Krenz, Jennifer L, Koehl, Lanting, Fuh, John T, Nagurney, Susan R, Wilcox, Bryan D, Hayes
Publikováno v:
The American Journal of Emergency Medicine. 62:133-135
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f06a61992f4e4d332c738fb276e01096
https://doi.org/10.1016/j.ajem.2022.09.001
https://doi.org/10.1016/j.ajem.2022.09.001
Publikováno v:
Journal of Pharmacy Practice and Research. 51:211-215
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::df540bb4910435409b9e68098deb8b1b
https://doi.org/10.1002/jppr.1732
https://doi.org/10.1002/jppr.1732
Autor:
Lanting Fuh, Shuroug A. Alowais, Jennifer Le, Bryan D. Hayes, Jennifer L. Koehl, Susan R. Wilcox
Publikováno v:
The American Journal of Emergency Medicine. 44:407-410
Patients who present with atrial fibrillation (AF) or flutter with rapid ventricular response (RVR) and hemodynamic stability may be managed with either an intravenous (IV) nondihydropyridine calcium channel blocker (CCB) or a beta-blocker (BB). Pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ffc12b0871d09c478f277ef0e55ba06
https://doi.org/10.1016/j.ajem.2020.04.093
https://doi.org/10.1016/j.ajem.2020.04.093
Autor:
Maguire, Michelle1, Lanting Fuh1, Goldstein, Joshua N.2,3, Marshall, Ariela L.4,5, Levine, Michael6, Howell, Melissa L.7, Parry, Blair A.2,8, Rosovsky, Rachel9,10, Hayes, Bryan D.1,3
Publikováno v:
Western Journal of Emergency Medicine: Integrating Emergency Care with Population Health. Jul2019, Vol. 20 Issue 4, p619-625. 7p.
Publikováno v:
Journal of Thrombosis and Thrombolysis. 50:217-220
Patients who require urgent warfarin reversal often receive four-factor prothrombin complex concentrate (4F-PCC), which is traditionally dosed according to weight and initial INR. Our institution implemented a fixed-dose 4F-PCC strategy, using an ini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::71568c95e20b315c22b22f6df93c4999
https://doi.org/10.1007/s11239-019-01984-w
https://doi.org/10.1007/s11239-019-01984-w
Autor:
Blair A. Parry, Michelle Maguire, Rachel P. Rosovsky, Lanting Fuh, Melissa L. Howell, Bryan D. Hayes, Ariela L. Marshall, Joshua N. Goldstein, Michael Levine
Publikováno v:
Western Journal of Emergency Medicine
Western Journal of Emergency Medicine, Vol 20, Iss 4 (2019)
Western Journal of Emergency Medicine, Vol 20, Iss 4 (2019)
Author(s): Maguire, Michelle; Fuh, Lanting; Goldstein, Joshua N.; Marshall, Ariela L.; Levine, Michael; Howell, Melissa L.; Parry, Blair A.; Rosovsky, Rachel; Hayes, Bryan D. | Abstract: Introduction: Warfarin is a potent anticoagulant used for the p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36352e32a30393e14667bbe0f08181ce
https://doi.org/10.5811/westjem.2019.4.41649
https://doi.org/10.5811/westjem.2019.4.41649
Autor:
Aman B. Patel, Eric Rosenthal, Joshua N. Goldstein, Megan E Barra, Alvin S. Das, Rachel P. Rosovsky, Russel J. Roberts, Lanting Fuh, Bryan D. Hayes
Publikováno v:
Journal of thrombosis and haemostasis : JTHREFERENCES. 18(7)
Background/objective Before approval of andexanet alfa, off-label treatment with 4-factor prothrombin complex concentrate (4F-PCC) was often utilized for the management of life-threatening hemorrhages associated with oral factor Xa inhibitors. We eva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9af7e7d61200fccc6e8bdfb1385c49b
https://pubmed.ncbi.nlm.nih.gov/32291874
https://pubmed.ncbi.nlm.nih.gov/32291874